143 related articles for article (PubMed ID: 8899664)
1. Serotonergic neurotransmission in the spinal cord and motor cortex of patients with motor neuron disease and controls: quantitative autoradiography for 5-HT1a and 5-HT2 receptors.
Forrest V; Ince P; Leitch M; Marshall EF; Shaw PJ
J Neurol Sci; 1996 Aug; 139 Suppl():83-90. PubMed ID: 8899664
[TBL] [Abstract][Full Text] [Related]
2. A quantitative autoradiographic study of [3H]kainate binding sites in the normal human spinal cord, brainstem and motor cortex.
Shaw PJ; Ince PG
Brain Res; 1994 Mar; 641(1):39-45. PubMed ID: 8019849
[TBL] [Abstract][Full Text] [Related]
3. Non-NMDA receptors in motor neuron disease (MND): a quantitative autoradiographic study in spinal cord and motor cortex using [3H]CNQX and [3H]kainate.
Shaw PJ; Chinnery RM; Ince PG
Brain Res; 1994 Aug; 655(1-2):186-94. PubMed ID: 7812772
[TBL] [Abstract][Full Text] [Related]
4. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
[TBL] [Abstract][Full Text] [Related]
5. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine.
Wieland S; Kreider MS; McGonigle P; Lucki I
Brain Res; 1990 Jun; 520(1-2):291-302. PubMed ID: 1698505
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord.
Marlier L; Teilhac JR; Cerruti C; Privat A
Brain Res; 1991 May; 550(1):15-23. PubMed ID: 1832328
[TBL] [Abstract][Full Text] [Related]
7. [3H]D-aspartate binding sites in the normal human spinal cord and changes in motor neuron disease: a quantitative autoradiographic study.
Shaw PJ; Chinnery RM; Ince PG
Brain Res; 1994 Aug; 655(1-2):195-201. PubMed ID: 7812773
[TBL] [Abstract][Full Text] [Related]
8. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartate (NMDA) receptors in the spinal cord and motor cortex in motor neuron disease: a quantitative autoradiographic study using [3H]MK-801.
Shaw PJ; Ince PG; Matthews JN; Johnson M; Candy JM
Brain Res; 1994 Feb; 637(1-2):297-302. PubMed ID: 7514083
[TBL] [Abstract][Full Text] [Related]
10. The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study.
Fray AE; Ince PG; Banner SJ; Milton ID; Usher PA; Cookson MR; Shaw PJ
Eur J Neurosci; 1998 Aug; 10(8):2481-9. PubMed ID: 9767379
[TBL] [Abstract][Full Text] [Related]
11. Autoradiographic distribution of binding sites for the non-NMDA receptor antagonist [3H]CNQX in human motor cortex, brainstem and spinal cord.
Chinnery RM; Shaw PJ; Ince PG; Johnson M
Brain Res; 1993 Dec; 630(1-2):75-81. PubMed ID: 7906998
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
13. Systemic morphine produce antinociception mediated by spinal 5-HT7, but not 5-HT1A and 5-HT2 receptors in the spinal cord.
Dogrul A; Seyrek M
Br J Pharmacol; 2006 Nov; 149(5):498-505. PubMed ID: 16921395
[TBL] [Abstract][Full Text] [Related]
14. Serotonin type-2 receptor mediated regulation of substance P release in the ventral spinal cord and the effects of chronic antidepressant treatment.
Iverfeldt K; Peterson LL; Brodin E; Ogren SO; Bartfai T
Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):1-6. PubMed ID: 2426604
[TBL] [Abstract][Full Text] [Related]
15. Expression of glutamate receptor subtypes in the spinal cord of control and mnd mice, a model of motor neuron disorder.
Mennini T; Bigini P; Ravizza T; Vezzani A; Calvaresi N; Tortarolo M; Bendotti C
J Neurosci Res; 2002 Nov; 70(4):553-60. PubMed ID: 12404509
[TBL] [Abstract][Full Text] [Related]
16. Motor neuron disease: a primary disorder of corticomotoneurons?
Pamphlett R; Kril J; Hng TM
Muscle Nerve; 1995 Mar; 18(3):314-8. PubMed ID: 7870109
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic manipulations in experimental neoplastic spinal cord compression.
Siegal T; Siegal T
J Neurosurg; 1993 Jun; 78(6):929-37. PubMed ID: 7683713
[TBL] [Abstract][Full Text] [Related]
18. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
Yamazaki J; Fukuda H; Nagao T; Ono H
Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic regulation of the spinal cord content of thyrotropin releasing hormone in the cerebellar ataxia mutant mouse.
Endo S; Itoh M; Serizawa O
J Neurol Sci; 1993 Sep; 118(2):194-201. PubMed ID: 8229069
[TBL] [Abstract][Full Text] [Related]
20. Neuron density and serotonin receptor binding in prefrontal cortex in suicide.
Underwood MD; Kassir SA; Bakalian MJ; Galfalvy H; Mann JJ; Arango V
Int J Neuropsychopharmacol; 2012 May; 15(4):435-47. PubMed ID: 21733245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
